Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshio Miyata

Showing results (31-40 of 217) with videos related to

Pageof 22
Sort By:
Chemical & Pharmaceutical Bulletin|May 13, 2010
Structure-activity relationships of new 2-acylamino-3-thiophenecarboxylic acid dimers as plasminogen activator inhibitor-1 inhibitorsNagahisa Yamaoka, Yasuhiko Kawano, Yuko Izuhara, et al.
Plos One|July 25, 2015
Small Molecule Inhibitors of Plasminogen Activator Inhibitor-1 Elicit Anti-Tumorigenic and Anti-Angiogenic ActivityVeronica R Placencio, Atsuhiko Ichimura, Toshio Miyata, et al.
Chemical & Pharmaceutical Bulletin|February 8, 2011
Structure-activity relationships of new N-acylanthranilic acid derivatives as plasminogen activator inhibitor-1 inhibitorsNagahisa Yamaoka, Hidehiko Kodama, Yuko Izuhara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2018
[Continuation of Axitinib for Advanced Renal Cell Carcinoma by The Application of Homecare Urology - A Case Report and Literature Review]Satoshi Yazawa, Yuji Kato, Jin Nakahara, et al.
Biochemical and Biophysical Research Communications|June 25, 2019
Blockade of plasminogen activator inhibitor-1 empties bone marrow niche sufficient for donor hematopoietic stem cell engraftment without myeloablative conditioningAbd Aziz Ibrahim, Takashi Yahata, Yukari Muguruma, et al.
British Journal of Pharmacology|June 25, 2016
A novel plasminogen activator inhibitor-1 inhibitor, TM5441, protects against high-fat diet-induced obesity and adipocyte injury in miceLingjuan Piao, Inji Jung, Joo Young Huh, et al.
Nature Reviews. Nephrology|July 6, 2011
New era for drug discovery and development in renal diseaseToshio Miyata, Katsushi Kikuchi, Hideyasu Kiyomoto, et al.
Kidney International|February 19, 2002
Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranesToshio Miyata, Olivier Devuyst, Kiyoshi Kurokawa, et al.
Skeletal Muscle|March 8, 2016
Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathwayJunchul Shin, Aki Nunomiya, Yasuo Kitajima, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2007
Establishment of a sandwich ELISA for human megsin, a kidney-specific serine protease inhibitorReiko Inagi, Yuko Izuhara, Naoto Tominaga, et al.
Pageof 22

Showing results (31-40 of 217) with videos related to

Sort By:
Pageof 22
Chemical & Pharmaceutical Bulletin|May 13, 2010
Structure-activity relationships of new 2-acylamino-3-thiophenecarboxylic acid dimers as plasminogen activator inhibitor-1 inhibitorsNagahisa Yamaoka, Yasuhiko Kawano, Yuko Izuhara, et al.
Plos One|July 25, 2015
Small Molecule Inhibitors of Plasminogen Activator Inhibitor-1 Elicit Anti-Tumorigenic and Anti-Angiogenic ActivityVeronica R Placencio, Atsuhiko Ichimura, Toshio Miyata, et al.
Chemical & Pharmaceutical Bulletin|February 8, 2011
Structure-activity relationships of new N-acylanthranilic acid derivatives as plasminogen activator inhibitor-1 inhibitorsNagahisa Yamaoka, Hidehiko Kodama, Yuko Izuhara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2018
[Continuation of Axitinib for Advanced Renal Cell Carcinoma by The Application of Homecare Urology - A Case Report and Literature Review]Satoshi Yazawa, Yuji Kato, Jin Nakahara, et al.
Biochemical and Biophysical Research Communications|June 25, 2019
Blockade of plasminogen activator inhibitor-1 empties bone marrow niche sufficient for donor hematopoietic stem cell engraftment without myeloablative conditioningAbd Aziz Ibrahim, Takashi Yahata, Yukari Muguruma, et al.
British Journal of Pharmacology|June 25, 2016
A novel plasminogen activator inhibitor-1 inhibitor, TM5441, protects against high-fat diet-induced obesity and adipocyte injury in miceLingjuan Piao, Inji Jung, Joo Young Huh, et al.
Nature Reviews. Nephrology|July 6, 2011
New era for drug discovery and development in renal diseaseToshio Miyata, Katsushi Kikuchi, Hideyasu Kiyomoto, et al.
Kidney International|February 19, 2002
Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranesToshio Miyata, Olivier Devuyst, Kiyoshi Kurokawa, et al.
Skeletal Muscle|March 8, 2016
Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathwayJunchul Shin, Aki Nunomiya, Yasuo Kitajima, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2007
Establishment of a sandwich ELISA for human megsin, a kidney-specific serine protease inhibitorReiko Inagi, Yuko Izuhara, Naoto Tominaga, et al.
Pageof 22